Used as a key intermediate in the synthesis of pharmaceutical agents targeting central nervous system disorders. Shows potential in the development of serotonin receptor modulators, particularly for treating anxiety, depression, and sleep disorders. Its structure supports binding affinity to specific neural receptors, making it valuable in neuropharmacology research. Also employed in the preparation of tryptamine-derived compounds with psychoactive and therapeutic properties. Commonly utilized in medicinal chemistry for structure-activity relationship (SAR) studies to optimize drug candidates.